The Inequitable Conduct Defense — 1 Year After Therasense
May 10, 2012, 1:13 PM EDT
Law360, New York (May 10, 2012, 1:13 PM EDT) -- In a case closely watched by patent litigators, the Federal Circuit Court of Appeals issued a decision last year that, on its face, seemed to impose tougher requirements for an accused patent infringer to establish that a patent is unenforceable because the patent applicant or the patent attorney intentionally withheld important information in obtaining the patent. Therasense Inc. v. Becton Dickinson & Co., 649 F.3d 1276 (Fed. Cir. 2011).
While commentators widely proclaimed that Therasense had raised the bar so high as to sound the death...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.